Biomarkers of Inflammatory Bowel Disease

被引:63
|
作者
Yi Fengming [1 ]
Wu Jianbing [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Oncol, Nanchang 330006, Jiangxi, Peoples R China
关键词
SACCHAROMYCES-CEREVISIAE ANTIBODIES; ACTIVE ULCERATIVE-COLITIS; FECAL PYRUVATE-KINASE; MEAN PLATELET VOLUME; C-REACTIVE PROTEIN; CROHNS-DISEASE; INTESTINAL INFLAMMATION; NONINVASIVE MARKER; DIAGNOSTIC-VALUE; INDETERMINATE COLITIS;
D O I
10.1155/2014/710915
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinvasive, cheap, rapid, and reproducible is helpful for patients and clinicians. Currently biomarkers applied in clinic include CRP, ESR, pANCA, ASCA, and fecal calprotectin. However, they are far from ideal. Lots of studies are focused on seeking for ideal biomarker for IBD. Herein, the paper reviewed recent researches on biomarkers of IBD to get advances of biomarkers in inflammatory bowel disease.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Longitudinal Study of Circulating miRNA Biomarkers in Inflammatory Bowel Disease
    Viennois, Emilie
    Baker, Mark
    Xiao, Bo
    Ayyadurai, Saravanan
    Laroui, Hamed
    Merlin, Didier
    GASTROENTEROLOGY, 2014, 146 (05) : S422 - S422
  • [42] Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
    Cornish, Jack S.
    Wirthgen, Elisa
    Daebritz, Jan
    FRONTIERS IN MEDICINE, 2020, 7
  • [43] Biomarkers in inflammatory bowel disease: current practices and recent advances
    Iskandar, Heba N.
    Ciorba, Matthew A.
    TRANSLATIONAL RESEARCH, 2012, 159 (04) : 313 - 325
  • [44] Do biomarkers help to optimize therapy in inflammatory bowel disease?
    Vermeire, S.
    IMMUNOREGULATION IN INFLAMMATORY BOWEL DISEASES - CURRENT UNDERSTANDING AND INNOVATION, 2007, 153 : 55 - 60
  • [45] Raman spectroscopic molecular fingerprinting of biomarkers for inflammatory bowel disease
    Buchan, Emma
    Rickard, Jonathan James Stanley
    Oppenheimer, Pola Goldberg
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (11):
  • [46] Myostatin and Activin A as Biomarkers of Sarcopenia in Inflammatory Bowel Disease Patients
    Godala, Malgorzata
    Gaszynska, Ewelina
    Walczak, Konrad
    Malecka-Wojciesko, Ewa
    NUTRIENTS, 2024, 16 (06)
  • [47] Fecal biomarkers in inflammatory bowel disease: how, when and why?
    Ministro, Paula
    Martins, Diana
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (04) : 317 - 328
  • [48] Serum biomarkers confirming stable remission in inflammatory bowel disease
    Kessel, Christoph
    Lavric, Miha
    Weinhage, Toni
    Brueckner, Markus
    de Roock, Sytze
    Daebritz, Jan
    Weber, Jakob
    Vastert, Sebastiaan J.
    Foell, Dirk
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [49] Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease
    Lucafo, Marianna
    Stankovic, Biljana
    Kotur, Nikola
    Di Silvestre, Alessia
    Martelossi, Stefano
    Ventura, Alessandro
    Zukic, Branka
    Pavlovic, Sonja
    Decorti, Giuliana
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (24) : 2855 - 2871
  • [50] Serum biomarkers confirming stable remission in inflammatory bowel disease
    Christoph Kessel
    Miha Lavric
    Toni Weinhage
    Markus Brueckner
    Sytze de Roock
    Jan Däbritz
    Jakob Weber
    Sebastiaan J. Vastert
    Dirk Foell
    Scientific Reports, 11